Related Experiment Video
Updated: Jul 1, 2026
09:00
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
Interactions between antitumor drugs and vault RNA.
Tsukasa Mashima1, Michiko Kudo, Yusuke Takada
1Supramolecular Biology, International Graduate School of Arts and Sciences, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Nucleic Acids Symposium Series (2004)
|September 9, 2008
Summary
Vault RNA hvg-2 interacts with specific antitumor drugs, suggesting a role in multidrug resistance. This interaction occurs at a common binding site, highlighting potential therapeutic targets.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Resistance Mechanisms
Background:
- Ribonucleoprotein particle vaults are implicated in cellular detoxification and multidrug resistance.
- Vaults comprise proteins and vault RNAs (hvg-1, -2, -3).
- Direct interactions between vault components and drugs remain largely uncharacterized.
Purpose of the Study:
- To investigate the interactions between vault RNA hvg-2 and six antitumor drugs.
- To elucidate the binding sites and affinities of these interactions.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy.
- Chemical shift perturbation (CSP) analysis.
Main Results:
- Vault RNA hvg-2 demonstrated interactions with mitoxantrone and two other antitumor drugs.
- Binding occurred at a common site on hvg-2, with varying affinities observed.
- No binding was detected between hvg-2 and the remaining three drugs.
Conclusions:
- Vault RNA hvg-2 recognizes a shared chemical structure among specific positively interacting antitumor drugs.
- These findings suggest a potential mechanism for vault-mediated drug resistance.
- hvg-2 represents a potential target for understanding and overcoming multidrug resistance.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...